bpc 157 for gout BPC-157 – Research Peptide What is BPC-157 (Body Protection
Description
Clinical trial data from the NEJM Phase 2 study showed that gastrointestinal events were predominantly mild to moderate, occurred primarily during dose escalation, and were partially mitigated by starting at 2mg rather than 4mg
PMC 12878028
0.5 mL : Ideal for doses between 30 to 50 units
Magnesium Chloride: Supports muscle relaxation, nerve function, and electrolyte balance
